Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort
Archive ouverte
Cuzin, Lise | Pugliese, Pascal | Katlama, Christine | Bani-Sadr, Firouzé | Ferry, Tristan | Rey, David | Lourenco, Jeremy | Allavena, Clotilde | Reynes, Jacques | Cabié, André | Drobacheff-Thiébaut, C | Foltzer, A | Bouiller, K. | Hustache-Mathieu, L | Chirouze, C. | Lepiller, Q. | Bozon, F | Babre, O | Muret, P. | Laurichesse, H., H. | Lesens, O. | Vidal, M | Mrozek, N | Aumeran, C. | Baud, O. | Corbin, V., V. | Letertre, P | Casanova, S. | Jacomet, C | Hoen, B. | Lamaury, I | Fabre, I | Curlier, E | Ouissa, R | Schepers, K | Herrmann-Storck, C | Dournon, N | Merrien, D | Perré, P. | Guimard, T | Bollangier, O | Leautez, S | Morrier, M | Ader, F. | Biron, F. | Boibieux, A. | Cotte, L. | Miailhes, P. | Perpoint, T. | Roux, S. | Degroodt, S | Brochier, C | Valour, F. | Chidiac, C. | Dhiver, C. | Mokhtari, M Saadia | Ménard, A | Dupont, H Tissot | Tomei, C. | Meddeb, L. | Belkhir, A. | Ravaux, I. | Bregigeon, Sylvie | Zaegel-Faucher, O. | Obry-Roguet, V. | Orticoni, M | Soavi, M | Luquet-Besson, I | Ressiot, E | Carta-Padovani, M | Ducassou, M. | Bertone, H | Galie, S | Galinier, A. | Monclar, M | Ritleng, A | Ivanova, A. | Blanco-Betancourt, C | Lions, C. | Poizot-Martin, I. | Abel, S. | Césaire, R. | Santos, G Dos | Fagour, L | Illiaquer, M | Najioullah, F. | Nguyen, D | Ouka, M | Pierre-François, S | Pasquier, J. | Pircher, M. | Rozé, B | Atoui, N | Moing, V Le | Makinson, A. | Meftah, N. | de Boever, C Merle | Montes, B. | Ferrer, a Montoya | André, M. | Boyer, L. | Bouillon, M | Delestan, M | May, T. | Bernaud, C | Billaud, E. | Biron, C | Bonnet, B | Bouchez, S | Boutoille, D. | Brunet-Cartier, C | Hall, N., M.J. | Jovelin, T. | Morineau, P | Reliquet, V. | Hue, H | Sécher, S | Cavellec, M | Soria, A. | Ferre, V. | André-Garnier, E. | Rodallec, A. | Guen, L Le | Lefebvre, M | Grossi, O | Point, P. | Aubry, O. | Khatchatourian, L | Raffi, F. | Breaud, S. | Ceppi, C | Courjon, J | Cua, E | Cottalorda, J. | Dellamonica, P. | Demonchy, E | Monte, a De | Durant, J. | Etienne, C | Ferrando, S | Fuzibet, J | Garraffo, R | Joulié, A. | Risso, K | Mondain, V. | Naqvi, A. | Oran, N. | Perbost, I | Pillet, S. | Prouvost-Keller, B | Pradier, C | Wehrlen-Pugliese, S | Rio, V | Rosenthal, E. | Sausse, S | Zouzou, G | Hocqueloux, L | Cheret, A | Goujard, C | Quertainmont, Y | Teicher, E. | Lerolle, N. | Vittecoq, D. | Deradji, O | Fourreau, F | Pallier, C. | Barrail-Tran, A | Landman, R | Joly, V | Rioux, C. | Lariven, S | Gervais, A | Lescure, F. | Matheron, S. | Louni, F | Godard, C | Julia, Z | Chansombat, M | Rahli, D | Mackoumbou-Nkouka, C | Charpentier, C. | Descamps, D. | Peytavin, G. | Yazdanpanah, Y. | Consigny, P | Cessot, G | Bossi, P | Goesch, J | Gilquin, J | Benabdelmoumen, G | Lanternier, F. | Charlier, C. | Amazzough, K. | Henry, B | Pilmis, B. | Rouzaud, C | Morgand, M. | Touam, F | Louisin, C | Duvivier, C. | Lortholary, O. | Guery, R. | Danion, F. | Parize, P. | Etienne, N | Launay, M. | Rouzioux, C. | Avettand Fenoel, V | Valantin, M | Flandre, P. | Caby, F. | Tubiana, R | Agher, R | Seang, S | Schneider, L | Palich, R | Blanc, C | Berger, J. | N’guyen, Y | Lambert, D. | Lebrun, D. | Kmiec, I | Hentzien, M. | Brodard, V | Botelho-Nevers, E. | Gagneux-Brunon, A. | Frésard, A. | Lucht, F. | Fischer, P | Partisani, M. | Cheneau, C. | Priester, M | Batard, M | Bernard-Henry, C | de Mautort, E | Alvarez, M. | Biezunski, N | Debard, A. | Delpierre, C. | Lansalot, P | Lelievre, L. | Martin-Blondel, Guillaume | Metsu, D | Piffaut, M | Porte, L. | Saune, K | Delobel, Pierre | Ajana, F | Alcaraz, I | Baclet, V | Boucher, A. | Choisy, P | Huleux, T. | Lafon-Desmurs, B. | Melliez, H | Meybeck, A | Pasquet, A. | Pradier, M | Robineau, O | Viget, N | Valette, M.
Edité par
CCSD ; Oxford University Press (OUP) -
International audience.
To analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor (INSTI), with a focus on neuropsychiatric adverse events (NPAEs).
